Cargando…
miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy
How the kidney responds to the metabolic cues from the environment remains a central question in kidney research. This question is particularly relevant to the pathogenesis of diabetic nephropathy (DN) in which evidence suggests that metabolic events in podocytes regulate chromatin structure. Here,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931323/ https://www.ncbi.nlm.nih.gov/pubmed/27350436 http://dx.doi.org/10.1038/ncomms12076 |
_version_ | 1782440871542652928 |
---|---|
author | Badal, Shawn S. Wang, Yin Long, Jianyin Corcoran, David L. Chang, Benny H. Truong, Luan D. Kanwar, Yashpal S. Overbeek, Paul A. Danesh, Farhad R. |
author_facet | Badal, Shawn S. Wang, Yin Long, Jianyin Corcoran, David L. Chang, Benny H. Truong, Luan D. Kanwar, Yashpal S. Overbeek, Paul A. Danesh, Farhad R. |
author_sort | Badal, Shawn S. |
collection | PubMed |
description | How the kidney responds to the metabolic cues from the environment remains a central question in kidney research. This question is particularly relevant to the pathogenesis of diabetic nephropathy (DN) in which evidence suggests that metabolic events in podocytes regulate chromatin structure. Here, we show that miR-93 is a critical metabolic/epigenetic switch in the diabetic milieu linking the metabolic state to chromatin remodelling. Mice with inducible overexpression of a miR-93 transgene exclusively in podocytes exhibit significant improvements in key features of DN. We identify miR-93 as a regulator of nucleosomal dynamics in podocytes. miR-93 has a critical role in chromatin reorganization and progression of DN by modulating its target Msk2, a histone kinase, and its substrate H3S10. These findings implicate a central role for miR-93 in high glucose-induced chromatin remodelling in the kidney, and provide evidence for a previously unrecognized role for Msk2 as a target for DN therapy. |
format | Online Article Text |
id | pubmed-4931323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-49313232016-07-12 miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy Badal, Shawn S. Wang, Yin Long, Jianyin Corcoran, David L. Chang, Benny H. Truong, Luan D. Kanwar, Yashpal S. Overbeek, Paul A. Danesh, Farhad R. Nat Commun Article How the kidney responds to the metabolic cues from the environment remains a central question in kidney research. This question is particularly relevant to the pathogenesis of diabetic nephropathy (DN) in which evidence suggests that metabolic events in podocytes regulate chromatin structure. Here, we show that miR-93 is a critical metabolic/epigenetic switch in the diabetic milieu linking the metabolic state to chromatin remodelling. Mice with inducible overexpression of a miR-93 transgene exclusively in podocytes exhibit significant improvements in key features of DN. We identify miR-93 as a regulator of nucleosomal dynamics in podocytes. miR-93 has a critical role in chromatin reorganization and progression of DN by modulating its target Msk2, a histone kinase, and its substrate H3S10. These findings implicate a central role for miR-93 in high glucose-induced chromatin remodelling in the kidney, and provide evidence for a previously unrecognized role for Msk2 as a target for DN therapy. Nature Publishing Group 2016-06-28 /pmc/articles/PMC4931323/ /pubmed/27350436 http://dx.doi.org/10.1038/ncomms12076 Text en Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Badal, Shawn S. Wang, Yin Long, Jianyin Corcoran, David L. Chang, Benny H. Truong, Luan D. Kanwar, Yashpal S. Overbeek, Paul A. Danesh, Farhad R. miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy |
title | miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy |
title_full | miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy |
title_fullStr | miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy |
title_full_unstemmed | miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy |
title_short | miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy |
title_sort | mir-93 regulates msk2-mediated chromatin remodelling in diabetic nephropathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931323/ https://www.ncbi.nlm.nih.gov/pubmed/27350436 http://dx.doi.org/10.1038/ncomms12076 |
work_keys_str_mv | AT badalshawns mir93regulatesmsk2mediatedchromatinremodellingindiabeticnephropathy AT wangyin mir93regulatesmsk2mediatedchromatinremodellingindiabeticnephropathy AT longjianyin mir93regulatesmsk2mediatedchromatinremodellingindiabeticnephropathy AT corcorandavidl mir93regulatesmsk2mediatedchromatinremodellingindiabeticnephropathy AT changbennyh mir93regulatesmsk2mediatedchromatinremodellingindiabeticnephropathy AT truongluand mir93regulatesmsk2mediatedchromatinremodellingindiabeticnephropathy AT kanwaryashpals mir93regulatesmsk2mediatedchromatinremodellingindiabeticnephropathy AT overbeekpaula mir93regulatesmsk2mediatedchromatinremodellingindiabeticnephropathy AT daneshfarhadr mir93regulatesmsk2mediatedchromatinremodellingindiabeticnephropathy |